Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,394,637 papers from all fields of science
Search
Sign In
Create Free Account
EPHA2 wt Allele
Known as:
ECK
, EPH Receptor A2 wt Allele
, EPHA2
Human EPHA2 wild-type allele is located within 1p36 and is approximately 32 kb in length. This allele, which encodes ephrin type-A receptor 2 protein…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
1p36
Axon Guidance
Ephrin Type-A Receptor 2, human
Homo sapiens
Expand
Broader (1)
EPHA2 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Erythropoietin‐Producing Hepatoma Receptor Tyrosine Kinase A2 Modulation Associates with Protective Effect of Prone Position in Ventilator‐induced Lung Injury
B. Park
,
M. H. Shin
,
+9 authors
M. Park
American Journal of Respiratory Cell and…
2017
Corpus ID: 4496397
&NA; The erythropoietin‐producing hepatoma (Eph) receptor tyrosine kinase A2 (EphA2) and its ligand, ephrinA1, play a pivotal…
Expand
2012
2012
Bernard ECK, La mort rouge. Homicide, guerre et souillure en Grèce ancienne (Collection d’Études anciennes. Série grecque, 145), Paris, « Les Belles Lettres », 2012.
Gabriela Cursaru
2012
Corpus ID: 194192914
2009
2009
Predictive Value of EphA 2 and EphrinA-1 Expression in Oesophageal Squamous Cell Carcinoma
Xu Feng
,
W. Zhong
,
+4 authors
Z. Suo
2009
Corpus ID: 212600452
The aim of this study was to analyse the protein and mRNA expressions of EphA2 and EphrinA-1 in oesophageal squamous cell…
Expand
2007
2007
Secularization, Legal Indeterminacy, and Habermas's Discourse Theory of Law
Mark C. Modak-Truran
2007
Corpus ID: 56263923
The unexpected vitality of religion has motivated scholars in many fields like anthropology, sociology, political science…
Expand
2006
2006
A Novel Mechanism for p53 to Regulate Its Target Gene ECK in Signaling Apoptosis
Y. Jin
,
Jianli Wang
,
Changhong Qiao
,
T. Hei
,
P. Brandt-rauf
,
Yuxin Yin
Molecular Cancer Research
2006
Corpus ID: 9772454
Transcription factor p53 regulates its target genes through binding to DNA consensus sequence and activating the promoters of its…
Expand
2001
2001
[Morphological results after eccentric perforating keratoplasty].
T. Riedel
,
B. Seitz
,
A. Langenbucher
,
G. Naumann
Der Ophthalmologe
2001
Corpus ID: 24693827
OBJECTIVE Due to unfavourable optical and immunological conditions, an eccentric position of the corneal transplant is limited to…
Expand
1998
1998
[Combined use of ECK-triggered 2D-phase contrast MR angiography and 2D-time-of-flight MR angiography for planning and follow up before and after vascular intervention of pelvic and leg arteries].
P. Reimer
,
M. Wilhelm
,
+7 authors
P. Peters
RöFo. Fortschritte auf dem Gebiet der R…
1998
Corpus ID: 33005176
PURPOSE To develop a strategy for the complete work-up of vessel lumen and vessel wall for planning and follow-up of radiological…
Expand
1996
1996
[Influence of qingdai compound capsule (QDCC) on the expression of c-myc in psoriatic keratinocytes].
J. Feng
,
H. Q. Xu
,
B. Su
Zhongguo Zhong xi yi jie he za zhi Zhongguo…
1996
Corpus ID: 37688515
In this immunohistochemical study the authors detected the expression of c-myc in keratinocytes (ECK) from 30 psoriatic patients…
Expand
1984
1984
Immunohistochemical localization of epidermal and Mallory body cytokeratin in undifferentiated epithelial tumors. Comparison with ultrastructural features.
H. Kahn
,
S. Huang
,
W. Hanna
,
R. Baumal
,
M. J. Phillips
American Journal of Clinical Pathology
1984
Corpus ID: 26108743
Twenty-one anaplastic tumors were studied by light microscopy (LM), immunoperoxidase staining using anti-epidermal cytokeratin…
Expand
1931
1931
GRADUAL OBLITERATION OF THE PORTAL VEIN AS A SUBSTITUTE FOR ECK-FISTULA.
L. Dragstedt
Science
1931
Corpus ID: 22364518
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE